Evidence map›Paper›PMID 41310650›Full record

ArticleBMC biology2025

Trajectory of genome editing technology.

Yonglun Luo, Stanislaus Antony Ceasar, Karim Benabdellah

Abstract readEditorial
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yonglun LuoDepartment of Biomedicine, Aarhus University, Aarhus, C 8000, Denmark. alun@biomed.au.dk.
Stanislaus Antony CeasarDivision of Plant Molecular Biology and Biotechnology, Department of Biosciences, Rajagiri College of Social Sciences, Cochin, Kerala, 683104, India. saceasar@rajagiri.edu.
Karim BenabdellahDepartment of Genomic Medicine, Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), Pfizer-University of Granada, Granada, 18016, Spain. karim.benabdel@genyo.es.

Funding

Consejería de Salud y Consumo of the Junta de Andalucía PI-0216-2024Consejería de Universidad, Investigación e Innovación under Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020) ProyExcel_00875Innovative Health Initiative Joint Undertaking Nr.101165643Lundbeck Foundation R396-2022-350M-ERA.Net3 9355 PIECRISCNicolas Monardes contract from Consejería de Salud y Consumo, Junta de Andalucía 0006/2018Novo Nordisk Fonden NNF21OC0072031, NNF21OC0068988
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41310650
PMCPMC12661890

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.